A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This is a study for people diagnosed with hypertension to compare 3 doses (75 mg, 150 mg, and
300 mg) of an experimental product, aliskiren in comparison to a placebo. Each patient is in
the study for 8 weeks